{"DataElement":{"publicId":"14660590","version":"1","preferredName":"Adverse Events Supplemental Qualifiers Dataset Pharmaceutical Excipient Adverse Event Attribution Scale","preferredDefinition":"The scale that indicates the relativeness of pharmaceutical excipients attribution to the adverse event.","longName":"SUPPAE_QVAL_AEATTRBTN","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14660589","version":"1","preferredName":"Adverse Events Supplemental Qualifiers Dataset Pharmaceutical Excipient Adverse Event Attribution","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the adverse events domain.:Any intentionally added component of a finished pharmaceutical product other than the claimed therapeutic or diagnostic ingredient(s). The excipients are added to facilitate administration or manufacture, improve product delivery, promote the consistent release and bioavailability of the drug, enhance stability, assist in product identification, or enhance other product characteristics. Pharmaceutical excipients do not affect therapeutic effects of the preparation or suitable tests or assays. The term does not apply to macromolecular compounds like albumin, or compounds like amino acids and sugars that are used in biological products, nor does it apply to process or product-related impurities (e.g. degradation products, residual solvents), or extraneous contaminants._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._To assign to a cause or source.","longName":"6819753v1.00:14660588v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6819753","version":"1","preferredName":"Adverse Events Supplemental Qualifiers Dataset","preferredDefinition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the adverse events domain.","longName":"C147185","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Events Supplemental Qualifiers Dataset","conceptCode":"C147185","definition":"A dataset containing supplemental information, specifically non-standard variables, to parent records in the adverse events domain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8DFF23F4-C1A1-5F5B-E053-F662850A7D89","latestVersionIndicator":"Yes","beginDate":"2019-07-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-18","modifiedBy":"ONEDATA","dateModified":"2019-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14660588","version":"1","preferredName":"Pharmaceutical Excipient Adverse Event Attribution","preferredDefinition":"Any intentionally added component of a finished pharmaceutical product other than the claimed therapeutic or diagnostic ingredient(s). The excipients are added to facilitate administration or manufacture, improve product delivery, promote the consistent release and bioavailability of the drug, enhance stability, assist in product identification, or enhance other product characteristics. Pharmaceutical excipients do not affect therapeutic effects of the preparation or suitable tests or assays. The term does not apply to macromolecular compounds like albumin, or compounds like amino acids and sugars that are used in biological products, nor does it apply to process or product-related impurities (e.g. degradation products, residual solvents), or extraneous contaminants._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._To assign to a cause or source.","longName":"C42637:C41331:C25358","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmaceutical Excipient","conceptCode":"C42637","definition":"Any intentionally added component of a finished pharmaceutical product other than the claimed therapeutic or diagnostic ingredient(s). The excipients are added to facilitate administration or manufacture, improve product delivery, promote the consistent release and bioavailability of the drug, enhance stability, assist in product identification, or enhance other product characteristics. Pharmaceutical excipients do not affect therapeutic effects of the preparation or suitable tests or assays. The term does not apply to macromolecular compounds like albumin, or compounds like amino acids and sugars that are used in biological products, nor does it apply to process or product-related impurities (e.g. degradation products, residual solvents), or extraneous contaminants.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Attribution","conceptCode":"C25358","definition":"To assign to a cause or source.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C5CAD26-3A72-288A-E063-731AD00A300E","latestVersionIndicator":"Yes","beginDate":"2023-12-12","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-12","modifiedBy":"MMADDINENI","dateModified":"2023-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C5CAD26-3A73-288A-E063-731AD00A300E","latestVersionIndicator":"Yes","beginDate":"2023-12-12","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-12","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"12/12/2023: Created DEC(CADSR0003181)-MM","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2519597","version":"1","preferredName":"Adverse Event Attribution Scale","preferredDefinition":"the scale for attribution to the adverse event.","longName":"AE_ATTR_SCALE","context":"NIDCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Possible","valueDescription":"POSSIBLE","ValueMeaning":{"publicId":"2562442","version":"1","preferredName":"POSSIBLE","longName":"2562442v1.00","preferredDefinition":"Capable of happening or occurring.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Possible","conceptCode":"C82490","definition":"Capable of happening or occurring.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C0F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-09-09","endDate":null,"createdBy":"MULLENT","dateCreated":"2002-09-09","modifiedBy":"MMADDINENI","dateModified":"2023-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D591019-7236-18AC-E044-0003BA3F9857","beginDate":"2006-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-09-13","modifiedBy":"ALAIS","dateModified":"2006-09-13","deletedIndicator":"No"},{"value":"Probable","valueDescription":"PROBABLE","ValueMeaning":{"publicId":"2562443","version":"1","preferredName":"PROBABLE","longName":"2562443v1.00","preferredDefinition":"A measure of the expectation of the occurrence of a particular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Probability","conceptCode":"C54154","definition":"A measure of the expectation of the occurrence of a particular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C0F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-09-09","endDate":null,"createdBy":"MULLENT","dateCreated":"2002-09-09","modifiedBy":"MMADDINENI","dateModified":"2023-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D591019-724B-18AC-E044-0003BA3F9857","beginDate":"2006-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-09-13","modifiedBy":"ALAIS","dateModified":"2006-09-13","deletedIndicator":"No"},{"value":"Definite","valueDescription":"DEFINITE","ValueMeaning":{"publicId":"2562444","version":"1","preferredName":"DEFINITE","longName":"2562444v1.00","preferredDefinition":"A subjective answer of very strong agreement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Definitely","conceptCode":"C114710","definition":"A subjective answer of very strong agreement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C0F9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-09-09","endDate":null,"createdBy":"MULLENT","dateCreated":"2002-09-09","modifiedBy":"MMADDINENI","dateModified":"2023-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D591019-725A-18AC-E044-0003BA3F9857","beginDate":"2006-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-09-13","modifiedBy":"ALAIS","dateModified":"2006-09-13","deletedIndicator":"No"},{"value":"Unlikely","valueDescription":"Unlikely","ValueMeaning":{"publicId":"2567630","version":"1","preferredName":"Unlikely","longName":"2567630","preferredDefinition":"A characteristic used to qualify the adverse event as unlikely related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, with a temporal relationship to the medical intervention which makes a causal relationship improbable, and in which other interventions or underlying disease provide plausible explanations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event Unlikely Related to Intervention","conceptCode":"C53257","definition":"A characteristic used to qualify the adverse event as unlikely related to the medical intervention. According to WHO causality assessment criteria of suspected adverse reactions it is applicable to a clinical event, including laboratory test abnormality, with a temporal relationship to the medical intervention which makes a causal relationship improbable, and in which other interventions or underlying disease provide plausible explanations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D53B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"MMADDINENI","dateModified":"2023-12-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6295E2E9-786B-96C8-E040-BB89AD4346A2","beginDate":"2009-02-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-10","modifiedBy":"ONEDATA","dateModified":"2009-02-10","deletedIndicator":"No"},{"value":"Unrelated","valueDescription":"Unrelated","ValueMeaning":{"publicId":"2567629","version":"1","preferredName":"Unrelated","longName":"2567629","preferredDefinition":"A characteristic used to qualify the adverse event as clearly not related to the medical intervention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event Unrelated to Intervention","conceptCode":"C53256","definition":"A characteristic used to qualify the adverse event as clearly not related to the medical intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D53A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"HARTLEYG","dateModified":"2016-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6295E2E9-7875-96C8-E040-BB89AD4346A2","beginDate":"2009-02-10","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-02-10","modifiedBy":"ONEDATA","dateModified":"2009-02-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2452834","version":"1","preferredName":"Scale","preferredDefinition":"an ordered reference standard.","longName":"C25664","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0D51E8D8-69DD-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D591013-0540-16CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-09-13","modifiedBy":"ALAIS","dateModified":"2009-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"SUPPAE_QVAL_AEBNOH_CNTRBFACT","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Pharmaceutical excipients adverse event attribution","url":null,"context":"COG"},{"name":"COG TEXT 1","type":"Alternate Question Text","description":"How likely was the benzyl alcohol a contributing factor?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C5CC9E6-CB7A-3048-E063-731AD00A43C2","latestVersionIndicator":"Yes","beginDate":"2023-12-12","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2023-12-12","modifiedBy":"MMADDINENI","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":"12/12/2023: Created CDE(CADSR0003181)-MM","unresolvedIssues":null,"deletedIndicator":"No"}}